Pharmacogenomics of CYP2C9: Functional and Clinical Considerations

AK Daly, AE Rettie, DM Fowler, JO Miners - Journal of personalized …, 2017 - mdpi.com
CYP2C9 is the most abundant CYP2C subfamily enzyme in human liver and the most
important contributor from this subfamily to drug metabolism. Polymorphisms resulting in …

Variability in bioavailability of small molecular tyrosine kinase inhibitors

M Herbrink, B Nuijen, JHM Schellens… - Cancer treatment reviews, 2015 - Elsevier
Small molecular tyrosine kinase inhibitors (smTKIs) are in the centre of the very quickly
expanding area of personalized chemotherapy and oral applicability thereof. The number of …

Phenolics Profiling of Carpobrotus edulis (L.) NEBr. and Insights into Molecular Dynamics of Their Significance in Type 2 Diabetes Therapy and Its Retinopathy …

S Sabiu, FO Balogun, SO Amoo - Molecules, 2021 - mdpi.com
Adverse effects associated with synthetic drugs in diabetes therapy has prompted the search
for novel natural lead compounds with little or no side effects. Effects of phenolic compounds …

[HTML][HTML] Investigation of in silico studies for cytochrome P450 isoforms specificity

Y Wei, L Palazzolo, OB Mariem, D Bianchi… - Computational and …, 2024 - Elsevier
Abstract Cytochrome P450 (CYP450) enzymes comprise a highly diverse superfamily of
heme-thiolate proteins that responsible for catalyzing over 90% of enzymatic reactions …

Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes

H Raunio, M Kuusisto, RO Juvonen… - Frontiers in …, 2015 - frontiersin.org
The adverse effects to humans and environment of only few chemicals are well known.
Absorption, distribution, metabolism, and excretion (ADME) are the steps of pharmaco …

Synthesis, molecular modeling, quantum mechanical calculations and ADME estimation studies of benzimidazole-oxadiazole derivatives as potent antifungal agents

UA Çevik, I Celik, A Işık, RR Pillai, TE Tallei… - Journal of Molecular …, 2022 - Elsevier
In this study, a series of new 3-((5-(4-(5-substitue-1H-benz [d] imidazol-2-yl) phenyl)-1, 3, 4-
oxadiazol-2-yl) thio)-1-phenyl propane-1-on (4a-4d) derivatives has been designed and …

Pharmacogenomics of the cytochrome P450 2C family: impacts of amino acid variations on drug metabolism

A Isvoran, M Louet, DL Vladoiu, D Craciun… - Drug Discovery …, 2017 - Elsevier
Highlights•The interindividual variability of CYP2C members and its impact in drug
metabolism are reviewed.•Current advances in molecular modeling of CYP2C …

Plant phenolics ferulic acid and p-coumaric acid inhibit colorectal cancer cell proliferation through EGFR down-regulation

N Roy, A Narayanankutty, PA Nazeem… - Asian Pacific Journal …, 2016 - journal.waocp.org
Background Colorectal cancer (CRC) or bowel cancer is one of the most important cancer
diseases, needing serious attention. The cell surface receptor gene human epidermal …

Emulating docking results using a deep neural network: a new perspective for virtual screening

S Jastrzebski, M Szymczak, A Pocha… - Journal of Chemical …, 2020 - ACS Publications
Docking is one of the most important steps in virtual screening pipelines, and it is an
established method for examining potential interactions between ligands and receptors …

CYP2J2 molecular recognition: a new axis for therapeutic design

A Das, AT Weigle, WR Arnold, JS Kim… - Pharmacology & …, 2020 - Elsevier
Cytochrome P450 (CYP) epoxygenases are a special subset of heme-containing CYP
enzymes capable of performing the epoxidation of polyunsaturated fatty acids (PUFA) and …